Document is current

Any future updates will be listed below

Successful correction of hemophilia by CRISPR/Cas9 genome editing in vivo: delivery vector and immune responses are the key to success

Crossref DOI link: https://doi.org/10.15252/emmm.201606325

Published Online: 2016-04-04

Published Print: 2016-05-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark